Safety and cardiovascular effects of multiple-dose administration of aripiprazole and olanzapine in a randomised clinical trial.
Dora KollerSusana AlmenaraGina P Mejía-AbrilMiriam Saiz-RodriguezPablo ZubiaurManuel RománDolores OchoaAneta WojniczSamuel MartínDaniel Romero-PalaciánMarcos Navares-GómezFrancisco Abad-SantosPublished in: Human psychopharmacology (2020)
OLA induced more cardiovascular changes; however, more ADRs were registered to ARI. In addition, some polymorphisms may explain the difference in the incidence of these effects among subjects.